The proposed pipeline for targeted sequencing of the data generated from long-read sequencing technology, where the two genes BRCA1 and BRCA2, which are recurrently mutated in breast cancer, were analyzed as an example of this workflow and an examination of its performance was described for future testing and implementation. This evidence concerns the gene BRCA1 and breast cancer.